Delivery Order SPE2DB20D1100-SPE2DB25FB0E7

Award Date 3/10/25
Potential Completion Date 3/31/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,100.15, is for the delivery of Pfizer COVID-19 vaccine doses between 2024-2025, under the Emergency Use Authorization (EUA) program. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,271.56 firm fixed-price delivery order is for the supply of 0.9 mL Pfizer COVID-19 vaccines for the 2024-2025 timeframe, under an Expanded Use Authorization (EUA). The contract has an ultimate completion date of November 15, 2024 and was awarded on October 24, 2024. Amerisourcebergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,129.80, is a Firm Fixed Price Delivery Order for the procurement of Pfizer COVID-19 vaccine doses for the 2024-2025 period, including an emergency use authorization (EUA) 0.9 ML product. The contract has an ultimate completion date of March 6, 2025 and was awarded on February 12, 2025. This...
This federal contract award is a delivery order valued at $1,129.80 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 0.9ML doses of the Pfizer COVID-19 vaccine for the 2024-2025 period, under the Emergency Use Authorization (EUA). The contract has an ultimate completion date of January 3, 2025 and is a firm fixed-price arrangement. This delivery order is part...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,622.03 delivery order is for the procurement of Pfizer COVID-19 vaccines for the 2024-2025 time period, including 0.9 mL dosages under an Emergency Use Authorization (EUA). The contract has an ultimate completion date of March 14, 2025 and is a Firm Fixed Price delivery order. There was no set-aside designation...
This federal contract award issued by the Defense Logistics Agency (DLA) provides Amerisourcebergen Drug Corp with a Firm Fixed Price Delivery Order for the supply of 0.9ML Pfizer COVID-19 vaccines for the 2024-2025 period, with an ultimate completion date of October 10, 2024. The contract has a ceiling value of $1,135.77 and does not have a set-aside designation. As a major pharmaceutical distributor, Amerisourcebergen will leverage its extensive supply chain network to deliver these critical...
This federal contract award is valued at $56,788.50 and was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the delivery of Pfizer COVID-19 vaccine doses during the 2024-2025 period, with an ultimate completion date of November 15, 2024. This contract is not designated with a set-aside requirement. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $2,149.73, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of Pfizer COVID-19 vaccines in the 2024-2025 timeframe. The contract has a ceiling value of $1,129.80 and is for 0.9 ml dosages under the Emergency Use Authorization (EUA). The contract is for a firm fixed price and does not have any set-aside designations. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This is a $1,525.97 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 0.9ml Pfizer COVID-19 vaccine doses for the 2023-2024 period under the Emergency Use Authorization (EUA). The contract has an ultimate completion date of May 10, 2024. There is no set-aside designation noted for this award. Amerisourcebergen holds a larger $999,999,999.00 Indefinite...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FB0E7
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,100.15, is a Firm Fixed Price Delivery Order that will provide 0.9ML of Pfizer COVID-19 vaccine doses for the 2024-2025 period, including the Emergency Use Authorization (EUA). The contract has an ultimate completion date of March 31, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is not designated as a set-aside.

Generated 6/9/25, 9:57 AM